CN103764100A - 有机溶剂中小肾上腺素能激动剂盐形式的制剂 - Google Patents

有机溶剂中小肾上腺素能激动剂盐形式的制剂 Download PDF

Info

Publication number
CN103764100A
CN103764100A CN201280036959.XA CN201280036959A CN103764100A CN 103764100 A CN103764100 A CN 103764100A CN 201280036959 A CN201280036959 A CN 201280036959A CN 103764100 A CN103764100 A CN 103764100A
Authority
CN
China
Prior art keywords
preparation
vasoconstrictor
norepinephrine
skin
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280036959.XA
Other languages
English (en)
Chinese (zh)
Inventor
威廉·E·法尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROCERTUS BIOPHARM Inc
Original Assignee
PROCERTUS BIOPHARM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROCERTUS BIOPHARM Inc filed Critical PROCERTUS BIOPHARM Inc
Publication of CN103764100A publication Critical patent/CN103764100A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201280036959.XA 2011-06-02 2012-03-09 有机溶剂中小肾上腺素能激动剂盐形式的制剂 Pending CN103764100A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492664P 2011-06-02 2011-06-02
US61/492,664 2011-06-02
PCT/US2012/028446 WO2012166227A1 (en) 2011-06-02 2012-03-09 Formulation of small adrenergic agonist salt forms in organic solvents

Publications (1)

Publication Number Publication Date
CN103764100A true CN103764100A (zh) 2014-04-30

Family

ID=47259712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280036959.XA Pending CN103764100A (zh) 2011-06-02 2012-03-09 有机溶剂中小肾上腺素能激动剂盐形式的制剂

Country Status (6)

Country Link
US (1) US20140343159A1 (enExample)
EP (1) EP2713988A4 (enExample)
JP (1) JP2014515400A (enExample)
CN (1) CN103764100A (enExample)
AU (1) AU2012262947A1 (enExample)
WO (1) WO2012166227A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2770731T3 (es) 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
EP3319607A4 (en) 2015-07-09 2019-04-03 Galderma S.A. METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
CN113453663B (zh) * 2019-01-10 2024-07-05 太阳医药工业有限公司 稳定的可注射肾上腺素水溶液
AU2022443966A1 (en) * 2022-03-04 2024-08-22 Vasodynamics Limited Topical compositions and methods.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101198362A (zh) * 2005-06-17 2008-06-11 威斯康星校友研究基金会 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643586A (en) * 1983-01-12 1987-02-17 Hansen Jens S Equipment and method for calibration of instruments having a temperature sensing unit
CA2154979A1 (en) * 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US7405080B2 (en) * 2000-03-23 2008-07-29 Voellmy Richard W Compositions and methods relating to prevention of chemotherapy-induced alopecia
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
WO2010001391A1 (en) * 2008-06-30 2010-01-07 Oron Zachar Dermal application of vasoconstrictors
US8969331B2 (en) * 2008-10-01 2015-03-03 Roman Kelner Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101198362A (zh) * 2005-06-17 2008-06-11 威斯康星校友研究基金会 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法

Also Published As

Publication number Publication date
AU2012262947A1 (en) 2014-01-16
EP2713988A4 (en) 2015-03-04
US20140343159A1 (en) 2014-11-20
JP2014515400A (ja) 2014-06-30
EP2713988A1 (en) 2014-04-09
WO2012166227A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
JP5989095B2 (ja) イブプロフェンの経皮組成物およびその使用方法
CA2931144C (en) Anti-infective methods, compositions, and devices
WO2011014850A2 (en) Topical eutectic-based formulations
EP2373305B1 (en) Transdermal pharmaceutical compositions comprising a serm
JP2011507826A (ja) トルペリゾンを含む医薬製剤
Monti et al. Topical formulations containing finasteride. Part I: In vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat
US10258595B2 (en) Pharmaceutical formulation for histone deacetylase inhibitors
KR20010041527A (ko) 국소적 항바이러스성 조성물로서 무기 아질산염 및유기산의 조성
JP2020114862A (ja) リドカインを配合した非水性貼付剤
AU2006299833A1 (en) Improved testosterone gel and method of use
CN103764100A (zh) 有机溶剂中小肾上腺素能激动剂盐形式的制剂
CN102657602B (zh) 3,5-二羟基-4-异丙基二苯乙烯壳聚糖凝胶剂及其制备方法
CN110139641B (zh) 外用组合物
RU2699674C1 (ru) Композиция для чрескожной абсорбции
JP2007530498A (ja) ４−ヒドロキシタモキシフェンの化学的に安定な組成物
CN103301093B (zh) 睾酮透皮吸收贴剂
CN117379398A (zh) 一种胍法辛透皮贴剂及其制备方法
HK1196782A (en) Formulation of small adrenergic agonist salt forms in organic solvents
US20250152524A1 (en) Topical compositions and methods
G'Iyosova TRANSDERMAL PATCHES
Aftab Polymeric transdermal drug delivery system of ramipril and repaglinide: in-vitro and ex-vivo evaluation
BR112014013926B1 (pt) composição farmacêutica aperfeiçoada para melhorar entrega transdérmica de inibidor de pde-5
HK1242222B (en) Transdermal pharmaceutical compositions comprising a serm
JP2014019697A (ja) 抗真菌外用組成物及び抗真菌外用組成物の適用方法
KR20150057134A (ko) 손발톱진균증 치료를 위한 테르비나핀-함유 경피흡수제제

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1196782

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140430

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1196782

Country of ref document: HK